NIAGEN BIOSCIENCE, INC. Business Combination, Consideration Transferred, Equity Interests Issued and Issuable
NIAGEN BIOSCIENCE, INC. (NAGE) reported Business Combination, Consideration Transferred, Equity Interests Issued and Issuable of $1.00 million for the 12-month period ending 2017-12-30, per its 10-K filed 2019-03-07.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Consideration Transferred and Preacquisition Equity Interest in Acquiree › Business Combination, Consideration Transferred
us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable · last filed 2019-03-07
- NIAGEN BIOSCIENCE, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2017-12-30 was $0.00.
- NIAGEN BIOSCIENCE, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2017-09-30 was $0.00.
- NIAGEN BIOSCIENCE, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2017-07-01 was $0.00.
- NIAGEN BIOSCIENCE, INC. business combination, consideration transferred, equity interests issued and issuable for the quarter ending 2017-04-01 was $1.00M.
- NIAGEN BIOSCIENCE, INC. business combination, consideration transferred, equity interests issued and issuable for fiscal 2017 was $1.00M.
| Period end | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 3 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 6 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 9 month | Business Combination, Consideration Transferred, Equity Interests Issued and Issuable 12 month |
|---|---|---|---|---|
| 2017-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $1.00M 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $1.00M 10-Q · filed 2017-11-09 | |
| 2017-07-01 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.00M 10-Q · filed 2017-08-10 | ||
| 2017-04-01 | $1.00M 10-Q · filed 2017-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |